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Gemella species are part of normal human flora. They are rarely associated with infections. As opportunistic pathogens, they
can cause life-threatening infection in individuals with risk factors. We present an unusual case of an elderly patient, with no
predisposing risk factors, who presented with respiratory tract infection and Gemella species bacteremia and suffered a stroke in
the absence of features of endocarditis.
1. Introduction
Gemella species (GS) are part of the normal flora of human
mucous membranes. First reported in 1917, GS are facultative
anaerobic, catalase-negative, gram-positive cocci. GS are
found in pairs, clusters, or chains. They have a typical gram-
positive cell wall structure but they easily decolorize during
the gram staining process rendering them gram variable.
These characteristics make them difficult to identify with
standard laboratory techniques and as such the actual preva-
lence of infection may be underestimated [1, 2]. As oppor-
tunistic pathogens,GS can cause life-threatening infections in
individuals with predisposing risk factors. We hereby report
a case of an elderly gentleman with no predisposing risk
factors for GS infection who presented with lower respiratory
tract infection and developedGS bacteremia with subsequent
dense hemiplegia with absent endocarditis features.
2. Case Report
An 82-year-old Caucasian male with no significant past
medical history presented with several days of fever, malaise,
minimally productive cough, and some confusion. He was
febrile with a rectal temperature of 40.4∘C, heart rate of
143/minute, blood pressure of 154/70mmHg, and respira-
tory rate of 20/minute with oxygen saturation of 98% in
room air. His physical examination revealed good dental
hygiene, no mucocutaneous lesions, few basal crackles on
lung auscultation, and no cardiac murmurs. He denied any
recent dental, genitourinary, or gastrointestinal procedures.
He was not on any immunosuppressant medications. His
white blood cell count was 15,100/𝜇L with 91.2% neutrophils.
Electrocardiogram showed sinus tachycardia. Chest radio-
gram showed clear lung fields, and a noncontrast head
computed tomography (CT) scan showed age related changes
with no acute process. Patient met the systemic inflamma-
tory response syndrome (SIRS) criteria and possible lower
respiratory tract infection. Two sets of blood cultures were
drawn and sputum was sent for gram staining and culture.
Patient was started on ceftriaxone and azithromycin. Sputum
culture showed Haemophilus influenzae beta-lactamase pos-
itive growth. By day three of hospitalization, blood cultures
became positive for gram-positive cocci considered to be
Staphylococcus species. Blood cultures were repeated and
vancomycin was added to the antibiotic regimen. Patient had
shown clinical and laboratory improvement with the above
regimen with resolution of SIRS criteria. By the fifth day, the
organism was identified as Gemella species (our laboratory
was unable to further identify the organism) and later that
day patient developed dense left hemiplegia and facial palsy.
A noncontrast head CT scan showed no acute areas of infarct.
A transthoracic echocardiogram was negative for vegetation
or any significant structural or valvular abnormality. Clinical
evidence of endocarditis was not appreciated and the patient
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did not meet modified Duke criteria for endocarditis or
possible endocarditis. Etiology of the stroke was considered
likely primary central nervous system vascular event, and
as such routine acute ischemic stroke management was
initiated. Unfortunately, shortly after the devastating stroke,
the patient passed away from complications related to his
initial stroke management and hence further imaging studies
could not be performed. Family declined autopsy. The repeat
set of blood cultures drawn on day three of hospitalization
remained negative.
3. Discussion
Gemella species are an unusual cause of human infections.
However, as opportunistic pathogens, they are known to
cause serious and fatal infections in both pediatric and adult
population with risk factors [3–5]. Predisposing risk factors
are underlying heart disease (valvular disease, hypertrophic
cardiomyopathy, myxoma, congenital heart disease, and
prosthetic valves), poor dental hygiene, diabetes mellitus,
intravenous drug use, steroid therapy, hepatorenal syndrome,
and dental and gastrointestinal procedures [1, 4, 6]. The
majority of cases reported are of endocarditis. Additionally,
cases of central nervous system infections, embolic stroke
from underlying endocarditis, lung abscess, peritonitis in
dialysis dependent patients, septic arthritis, and sepsis have
also been reported [2–9]. Confirmation of infection is by bac-
terial isolation and performing phenotypic observation for
morphology. Gemella should be of consideration, especially
in high risk individuals, with endovascular infections when
standard methods identify slow growing catalase-negative
gram-positive cocci. Newer technique, 16S rRNA gene anal-
ysis, may be more efficient and accurate in the identification
of Gemella spp. [1, 2, 7]. Most cases of infections are suc-
cessfully treated with antimicrobial therapy alone. Penicillin
in combination with gentamicin, and in penicillin allergic
or resistant cases, vancomycin monotherapy, or combination
of erythromycin and rifampin had been successful [2, 4, 5].
Early surgical intervention is needed where appropriate.
4. Conclusion
Gemella species, as opportunistic pathogens, can cause life-
threatening infections in individuals with predisposing risk
factors. As noted in our case, usual risk factors may not
be always present but advanced age should be considered
a predisposing risk factor for Gemella species infection.
Primary respiratory tract infection and infections or disrup-
tion of the gastrointestinal and genitourinary tract mucosa
could lead to invasion and secondary infection with Gemella
species as they are normal flora of these tracts. As such, in
these circumstances, Gemella species infection should be of
consideration when culturemedia demonstrate slow growing
gram-positive organism. Our case is unusual in that Gemella
species bacteremia was noted without any endovascular or
other organ involvement that could be identified.The cause of
our patient’s stroke is likely related to primary central nervous
system vascular disease but the possibility of septic emboli
related to Gemella species endocarditis could not be entirely
ruled out.
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